
Healthways ( HWAY +9.5% ) pops after Dougherty upgraded the shares to Buy earlier today, saying there are extraordinary opportunities remaining
Healthways ( HWAY ): Q1 EPS of -$0.08 misses by $0.08 . Revenue of $165.2M (+1.3% Y/Y) beats by $10M . ( PR ) Post your comment!
3%, the prospects of a steep decline in the ranks of the uninsured are rather bleak; according to the latest Gallup- Healthways Well-Being Index , we are still looking at roughly 17% of the population without health insurance. Medicaid enrollment
On June 20, American Healthways AMHC reported strong sales and earnings growth for its fiscal ..... earnings. We are enthusiastic about the prospects for American Healthways ' business, but lukewarm regarding the prospects for its stock
Healthways ( HWAY -10% ) takes a hit after its Q4 misses estimates across the board. Net profits rose marginally Y/Y, but not enough to offset
By Kapitall : Looking for hidden gems in the biotech industry? If you are, the following list might offer a good starting point for your own analysis. To create this list, we started with a universe of rebounding biotech stocks. The stocks mentioned below are all trading far below their 200-day ...
Healthways ( HWAY ) revises guidance lower , now expecting to post a net loss for the year due to expenses stemming from Cigna's decision to allow
Dec 20 - Healthways Inc cut its full-year adjusted earnings outlook for the second time in two months, citing the wind-down of a contract with Cigna Corp and anticipated delay in receiving revenue...
Healthways ( HWAY +5.6% ), which was crushed in October on news of a Cigna ( CI ..... Stifel upgrades shares to Buy and lifts its PT to $13. The firm notes Healthways ' margins have held up well in the face of declining revenue, and
NEW YORK, Oct 25 (Reuters) - Small- and mid-capitalization stocks slid on Tuesday, with shares of Healthways tumbling on planned changes in its Cigna contract.